Responses
Global Ophthalmology
Original research
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
Compose a Response to This Article
Other responses
No responses have been published for this article.